Abstract
We have tested a novel strategy of intracellular immunization to block human immunodeficiency virus (HIV) infection. The expression of a specific antibody within a cell was achieved by transduction of genes that encode for immunoglobulin chains with specificity to viral reverse transcriptase. We demonstrated that inhibition of this enzyme makes cells resistant to HIV infection by blocking an early stage of viral replication. If high efficiency transduction with a stable vector into lymphohaematopoietic stem cells or mature lymphocytes can be achieved, gene transfer-mediated intracellular immunization might be a feasible treatment strategy in AIDS.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Baltimore, D. Intracellular immunization. Nature 335, 395–396 (1988).
Trono, D., Feinberg, M.B. & Baltimore, D. HIV-1 Gag mutants can domi-nantly interfere with the replication of the wild-type virus. Cell 59, 113–120 (1989).
Sullenger, B.A., Gallardo, H.F., Ungers, G.E. & Gilboa, E. Overexpression of Tar sequences renders cells resistant to human immunodeficiency virus replication. Cell 63, 601–608 (1990).
Yu, M. et al. A hairpin ribozyme inhibits expression of diverse strains of human immunodeficiency virus type 1. Proc. natn. Acad. Sci. U.S.A. 90, 6340–6344 (1993).
Sarver, N. et al. Ribozymes as potential anti-HIV-1 therapeutic agents. Science 247, 1222–1225 (1990).
Shimada, T.M. et al. Trial of antisense RNA inhibition of HIV replication and gene expression. Antiviral Chem. Chemother. 2, 133–142 (1991).
Caruso, M. & Klatzmann, D. Selective killing of CD4+ cells harboring a human immunodeficiency virus-inducible suicide gene prevents viral spread in an infected population. Proc. natn. Acad. Sci. U.S.A. 89, 182–186 (1992).
Travis, J. Putting antibodies to work inside cells. Science 261, 1114 (1993).
Carlson, J.R. A new means of inducibly inactivating a cellular protein. Molec. cell. Biol. 8, 2638–2646 (1988).
Biocca, S., Pierandrei-Amaldi, P., Campioni, N. & Cattaneo, A. Intracellular immunization with cytosolic recombinant antibodies. BioTechnology 12, 396–399 (1984).
Tavladoraki, P., Benvenuto, S.T., De Martinis, D., Cattaneo, A. & Galeffi, P. Transgenic plants expressing a functional single-chain Fv antibody are specifically protected from virus attack. Nature 366, 469–472 (1993).
Marasco, W.A., Haseltine, W.A. & Chen, S.Y., Design, intracellular expression, and activity of a human anti-human immunodeficiency virus type 1 gp120 single-chain antibody. Proc. natn. Acad. Set U.S.A. 90, 7427–7429 (1993).
Duan, L., Bagasra, O., Laughlin, M.A., Oakes, J.W. & Pomerantz, R.I. Potent inhibition of human immunodeficiency virus type 1 replication by an intracellular anti-Rev single chain antibody. Proc. natn. Acad. Sci. U.S.A. 91, 5015–5019 (1994).
Mullinax, R.L. et al. Identification of human antibody fragment clones specific for tetanus toxoid in a bacteriophage lambda immunoexpression library. Proc. natn. Acad. Sci. U.S.A. 87, 8095–8099 (1990).
Huse, W.D. et al. Generation of a large combinational library of the immunoglobulin repertoire in phage lambda. Science 246, 1275–1281 (1989).
Pluckthun, A. Antibody engineering: Advances from the use of Escherichia coli expression systems. BioTechnology 9, 545–551 (1991).
DiMarzo Veronese, F. et al. Characterization of highly immunogenic p55/p66 as the reverse transcriptase of HTLV-III/LAV. Science 231, 1289–1291 (1976).
Yates, J., Warren, N. & Sugden, B. Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells. Nature 313, 812–815 (1985).
Hambor, J.E. et al. Use of an Epstein-Barr virus episomal replicon for anti-sense RNA-mediated gene inhibition in a human cytotoxic T-cell clone. Proc. natn. Acad. Sci. U.S.A. 85, 4010–4014 (1988).
Young, J.M. et al. Utilization of Epstein-Barr virus replicon as a eukaryotic expression vector. Gene 62, 171–185 (1988).
Groger, R.K., Morrow, D.M. & Tykocinski, M.L. Directional antisense and sense cloning using Epstein-Barr virus episomal expression vectors. Gene 81, 285–294 (1989).
Karin, M. et al. Characterization of DNA sequences through which cadmium and glucocorticoid hormones induce human metallothionein-IIA gene. Nature 308, 513–519 (1984).
Pauwels, R. et al. Rapid and automated tetrazolium-based assay for the detection of anti-HIV compounds. J. virol Meth. 20, 309–321 (1988).
Gerna, G. et al. Effect of Foscarnet induction treatment on the quantitation of human cytomegalovirus (HCMV) DNA in peripheral blood polymor-phonuclear leucocytes and aqueous humor of AIDS patients with HCMV re-tinitis. Antimicrob. Agents Chemother. 38, 38–44 (1984).
Ou, C.-Y. et al. DNA amplification for direct detection of HIV-1 in DNA of peripheral blood mononuclear cells. Science 239, 295–297 (1988).
Lori, F. et al. Viral DNA carried by human immunodeficiency virus type 1 virions. J. Virol. 66, 5067–5074 (1992).
Cara, A., Guarnaccia, F., Reitz, M.S., Gallo, R.C. & Lori, F. Self limiting, cell type dependent replication of an integrase-defective HIV-1 in primary macrophages, but not T-lymphocytes. Virology 208, 242–248 (1995).
Zack, J.A. et al. HIV-1 entry into quiescent primary lymphocytes: Molecular analysis reveals a labile latent viral structure. Cell 61, 213–222 (1990).
Bukrinsky, D. et al. Active nuclear transport of human immunodeficiency virus type 1 preintegration complexes. Proc. natn. Acad. Sci. U.S.A. 89, 6580–6584 (1992).
Peng, L. et al. Initiation of reverse transcription during cell-to-cell transmission of human immunodeficiency virus infection uses pre-existing reverse transcriptase. J. gen. Virol 75, 1917–1926 (1994)
Withlow, M. & Filpula, D., Fv proteins and their fusion proteins. Meth. Enzym. 2, 97–105 (1991).
Huston, J.S. et al. Protein engineering of antibody binding sites: Recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Es-cherichia coli . Proc. natn. Acad. Sci. U.S.A. 85, 5879–5883 (1988).
Tai, M.-S. et al. A bifunctional fusion protein containing Fc-binding Fragment of staphylococcal protein A amino terminal to antidigoxin single-chain Fv. Biochemistry 29, 8024–8030 (1990).
Gilboa, E., Eglitis, M.A., Kantoff, P.W. & Anderson, F. Transfer and expression of cloned genes using retroviral vectors. BioTechniques 4, 584–512 (1986).
Tratschin, J.-D., Miller, I.L., Smith, M.G. & Carter, B.J. Adeno-associated virus vector for high-frequency integration, expression and rescue of genes in mammalian cells. Molec. cell. Biol. 5, 3251–3260, (1985).
Woffendin, C. et al. Nonviral and viral delivery of a human immunodeficiency virus protective gene into primary human T cells. Proc. natn. Acad. Sci. U.S.A. 91, 11581–11585 (1994).
Muro-Cacho, C.A., Samulski, R-J. & Kaplan, D. Gene transfer in human lymphocytes using a vector based on adeno-associated virus. J. Immunother. 11, 231–237 (1992).
Dunbar, C.E. & Emmons, R.V.B. Gene transfer into hematopoietic progenitor and stem cells: Progress and problems. Stem Cells 12, 563–576 (1994).
Dunbar, C.E. et al. Retrovirally-marked CD34-enriched blood and bone marrow cells contribute to long-term engraftment after autologous transplantation. Blood (in the press).
Brenner, M.K. et al. Gene-marking to trace origin of after autologous bone marrow transplantation. Lancet 341, 85–90 (1993).
Talbott, R., Krous, G., Looney, D. & Wong-Staal, F. Mapping the determinants of human immunodeficiency virus-2 for infectivity, replication efficiency, and cytopathicity. Proc. natn. Acad. Sci. U.S.A. 90, 4226–4229 (1993).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Maciejewski, J., Weichold, F., Young, N. et al. Intracellular expression of antibody fragments directed against HIV reverse transcriptase prevents HIV infection in vitro. Nat Med 1, 667–673 (1995). https://doi.org/10.1038/nm0795-667
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/nm0795-667
This article is cited by
-
Baculovirus display of single chain antibody (scFv) using a novel signal peptide
BMC Biotechnology (2010)
-
Anti-HIV ribozymes
Molecular Biotechnology (1997)
-
Targeting HIV reverse transcriptase in novel ways
Nature Medicine (1995)